Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease

Luigi Zecca; Christian Pifl; Stanley Fahn; David Sulzer; Ruggero G Fariello

doi:10.1038/s41531-020-00149-4

Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease

NPJ Parkinsons Dis. 2021 Jan 4;7(1):1. doi: 10.1038/s41531-020-00149-4.

Authors

Luigi Zecca¹, Christian Pifl², Stanley Fahn³, David Sulzer⁴, Ruggero G Fariello⁵

Affiliations

¹ Institute of Biomedical Technologies, National Research Council of Italy, Segrate, Milan, Italy. luigi.zecca@itb.cnr.it.
² Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
³ Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University and the New York Presbyterian Hospital, New York, NY, 10032, USA.
⁴ Departments of Psychiatry, Neurology, Pharmacology, Columbia University Medical Center, New York State Psychiatric Institute, New York, NY, 10032, USA.
⁵ PharmaFox Therapeutics AG, Möhlin, Aargau, Switzerland.

Abstract

Oleh Hornykiewicz (November 17, 1926–May 26, 2020), by demonstrating the loss of dopamine neurons in Parkinson’s disease, introducing the effort to treat the disorder with L-DOPA, and other innovative research, improved the lives of countless individuals and transformed neurology and medical science. Here we celebrate the life and great achievements of an outstanding scientist.

Publication types

Editorial